Early detection of cancer;Krebsfrüherkennung

Onkologe

Volumn 10, Issue 2, 2004, Pages 175-186

  Kath, R ^a  

^a Medizinische Klinik I   (Germany)

Author keywords

Breast cancer; Cancer screening; Cervical cancer; Colon cancer; Early detection

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLON CANCER; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HUMAN; PRACTICE GUIDELINE; PROSTATE CANCER; REVIEW; UTERINE CERVIX CANCER;

EID: 1542314747     PISSN: 09478965     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00761-003-0624-9     Document Type: Review

References (47)

1. Armstrong K, Eisen A, Weber B (2000) Assessing the Risk of Breast Cancer. N Engl J Med 342:564-571
2. de Koning HJ, Auvinen A, Berenguer SA, Calafs DS, Ciatto S, Denis L et al. (2002) Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer 97:237-244
3. Cassileth BR, Clark WH, Lusk EJ, et al. (1986) How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol 14:555-560
4. Chirenje ZM et al. (2001) Situation analysis for cervical cancer diagnosis and treatment in East, Central and Southern African countries. Bulletin World Health Organization 79:127-132
5. Eddy DM (1990) Screening for cervical cancer. Ann Int Med 113:214
6. Engel J, Baumert J, Dirschedl P, Sauer H, Hölzel D (2000) Wirksamkeit der Selbstuntersuchung, Palpation und Mammographie zur Früherkennung des Mammakarzinoms: Erste Ergebnisse der Feldstudie München. Geburtshilfe Frauenheilkd 60:155-164
7. Farmer ER, Gonin R, Hanna MP (1996) Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 27:528-531
8. Fontana RS, Sanderson DR, Woolner LB (1986) Lung cancer screening: The Mayo Program. J Ocup Med 28:746-750
9. Gates TJ (2001) Screening for cancer: Evaluating the evidence. Am Fam Physician 63:513-522
10. Gatta G, Capocaccia R, Sant M, Bell, CMJ, Coebergh JWW, Damhuis, RAM, Faivre J, Martinez-Garcia C, Pawlega J, Ponz de Leon M, Pottier, D, Raverdy N, Williams EMI, Berri-nom F (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 47:533-538
11. Gerber GS, Thompson IM, Thisted R, Chodak GW (1993) Disease-specific survival following routine prostate cancer screening by digital rectal examination. Jama 269:61-64
12. Gibis B, Busse R, Reese K, Richter K, Schwartz FW, Köbberling J (1998) Das Mammographie-Screening zur Brustkrebsfrüherkennung. Nomos, Baden-Baden
13. Goetzsche P, Olsen O (2000) Is Screening for Breast Cancer With Mammography Justifiable? Lancet 355:129-134
14. Hakama M, Miller AB, Day NE (eds) (1986) Screening for Cancer of the Uterine Cervix. Lyon, International Agency for Research on Cancer. IARC Scientific Publications 76:133-144
15. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, Balfour TW, Amar SS, Armitage NC, Moss SM (1989) Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1:1160-1164
16. Holmberg L, Bill-Axelson A, Helgerson F, et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer N Engl J Med 347:781-789
17. Hölzel D, Klamert DA, Schmidt M (1996) Krebs - Häufigkeiten, Befunde und Behandlungsergebnisse - Perspektiven für die Krebsdiskussion und eine quantitative klinisch-epidemiologische Onkologie aus dem Tumorregister München. Zuckschwerdt, München Bern Wien New York
18. Imperiale TF, Wagner DR, Lin CY (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings N Engl J Med 343:169-174
19. Jost LM (1997) Tumorscreening unter besonderer Berücksichtigung von Mamma- und Prostatakarzinom. Therapeutische Umschau 54:439-450
20. Levin B, Brooks D, Smith RA, Stone A (2003) Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin 53:44-55
21. Kerlikowske K, Barclay J (1997) Outcomes of modern screening mammography. J Natl Cancer Inst Monogr 22:105-111
22. Khandker, Dulski JM, Kilpatrick JB (2000) Cost-Effectiveness Analysis of Colorectal Cancer Screening and Surveillance Guidelines. Agency Healthcare Research Quality:(00-R051)
23. Koh HK (1991) Cutaneous melanoma. N Engl J Med 325:171-182
24. Koh HK, Geller AC, Miller DR, Lew RA (1995) The early detection of and screening for melanoma. Cancer 75:674-683
25. Kronberg O (2002) Colon polyps and cancer. Endoscopy 34:69-72
26. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328:1365-1371
27. McKie RM, Hole D (1992) Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 304:1012-1015
28. Melamed MR, Flehniger BZ, Zaman MB (1984) Screening for early lung cancer. Chest 86:44-53
29. Miller AB, Chamberlain J, Day NE, Hakama K, Prorok PC (1990) Report on a workshop of the UICC project on evaluation for screnning. Int J Cancer: 46:761-769
30. Oliver SE, Gunnell D, Donovan JL (2000) Comparison oftrends in prostate-cancer mortality in England and Wales and the USA. Lancet 355:1788-1878
31. Olsen O und Goetzsche P (2001) Cochrane review on screening for breast cancer with mammography. Lancet 358:1340-1342
32. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ (2003) National Evaluation Team for Breast Cancer Screening. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003 361:1411
33. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT (2003) Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 326:901
34. Rampen FHJ, Idy JAM, Velson C, et al. (1995) False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol 33:59-63
35. Rex D (2002) Current colorectal cancer screening strategies: overview and obstacles to implementation. Advances Colorectal Cancer Screening 2:S2-11
36. Richman S, Adlard J (2002) Left and right sided large bowel cancer. BMJ 324:931-932
37. Riemann JM, Management & Krankenhaus 2/2002. GIT, Darmstadt, 59
38. Ries LA, Kosary CL, Hankey BF, et al. (eds) (1998) SEER Cancer Statistics Review 1973-1995. Bethesda, Md: National Cancer Institute
39. Sharma VK, Vasudeva R, Howden CW (2000) Colorectal cancer screening and surveillance practices by primary physicians: results of a national survey Am J Gastroenterol 95:1551-1556
40. Smith RA, Cokkinides V, Eyre HJ (2003) American Cancer Society Guidelines for the early detection of cancer 53:27-43
41. Sonnenberg A, Delcò F, Inadomi JM (2000) Cost-effectiveness of screening for colorectal cancer. Ann Intern Med 133:573-584
42. Tabar L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW (2003) Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 361:1405-1410
43. Tockman MS (1986) Survival and mortality from lung cancer in a screened population. Chest 89:3245-3255
44. UK Flexible Sigmoidoscopy Screening Trial Investigators (2002) Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359:1291-1300
45. Urban N, McIntosh MW, Andersen MR, Karlan BY (2003) Ovarian Cancer Screening. Hematol Oncol Clin N An 17:989-1005
46. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardello FM, Sisk JE, van Antwerp R, Brown-Davis C, Marciniak, DA, Mayer RJ (1997) Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112:594-642
47. Windeler J, Perleth M, Antes G (2003) PSA Screening. Die Zeit ist nicht reif. Dtsch Ärztebl 39:B2077-2078